All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, August 10, 2022
Home » Blogs » BioWorld MedTech Perspectives » Lack of awareness, education biggest obstacles to innovation

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Lack of awareness, education biggest obstacles to innovation

April 22, 2011
By Omar Ford
No Comments

For nearly eight years my mother has been on anticoagulants. Because of this, she has to drive down to her local hospital every two weeks or so and clinicians test her blood to see if she is in danger of developing a blood clot.

In theory it seems pretty simple, and pretty painless. But in reality it can be pretty taxing. Although the visits last 20 minutes or so, my mother has had to plan her life around these “events.” Vacations have been cut short and travel plans now almost always include looking for an institution that will be able to test her blood, and send the information back to her doctors in a timely fashion.

If only we had known that there’s a simpler solution to all this. There is technology out there now that could allow patients like my mother take these test from home and send the results to their doctors.

The question then becomes, why aren’t we seeing more doctors push technologies such as this? Quite frankly, I think it comes down to an aspect that med-tech companies sometimes gloss over – the education piece.  

Companies need to have the sufficient capital to make education about their products, a stronger part of the post FDA approval piece. Now I’m just singling out this particular instance to make my point, but I wonder how many more patients out there are unaware of technology that could be beneficial to them. How many more patients are falling through the cracks because their doctors are unaware, or don’t have enough information to recommend a particular product.

Once I told my mother about the test, she was intrigued and she’s looking into the matter further.  I suspect it will take some discussion with her doctors before she is equipped with this new technology, but at least now she’s headed in the right direction and is finally aware of this life changing option.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 9, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Aug. 9, 2022.
  • Amvuttra

    Alnylam’s Amvuttra rare disease drug among positive recommendations from Europe’s CHMP

    BioWorld
    Alnylam Pharmaceuticals Inc.’s Amvuttra (vutrisiran), a treatment for the rare disease hereditary transthyretin-mediated amyloidosis, was among medicines...
  • Pig organ cells

    Whole body cellular function recovery in pigs after death

    Science
    A new system for restoring cell function and tissues in mammals after death could expand the availability of organs for transplantation. The research also opens...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing